National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
Latest action · Apr 18, 2018 Referred to the House Committee on Energy and Commerce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedApr 18, 2018
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
This bill authorizes the Food and Drug Administration to partner with institutions of higher education to designate them as National Centers of Excellence in Continuous Pharmaceutical Manufacturing for the purpose of studying and recommending improvements to the process of continuous manufacturing of medications. (Currently, most medications are manufactured in batches.)
Cosponsors 1
Members who signed on, in the order they did. All signed on Apr 18, 2018.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-KY | Brett Guthrie | Original | Apr 18, 2018 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Apr 18, 2018 |
Actions 2
Everything that happened, newest first.
- Apr 18, 2018Introduced in House
- Apr 18, 2018Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 164, no. 63, April 18, 2018, page H3443.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 4866 | National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2020 | Reintroduced Bill | Sep 22, 2020 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the 21st Century Cures Act to provide for designation of institutions of higher education that provide research, data, and leadership on continuous manufacturing as National Centers of Excellence in Continuous Pharmaceutical Manufacturing, and for other purposes.
- Short Titles as Introduced
- National Centers of Excellence in Continuous Pharmaceutical Manufacturing Act of 2018
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Advanced technology and technological innovations
- Congressional oversight
- Drug safety, medical device, and laboratory regulation
- Educational facilities and institutions
- Government information and archives
- Health
- Health programs administration and funding
- Health technology, devices, supplies
- Higher education
- Manufacturing
- Prescription drugs
- Product development and innovation
- Research administration and funding
- Research and development
Text 1
Each version as it was printed, newest first.
- Apr 18, 2018Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
